Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1215)	7/13/2005 12:56:02 PM
From: Jibacoa	Respond to of 3722

CALP Has not closed yesterday's upgap. It is testing its new support at the 6 level.<g> bigcharts.marketwatch.com It said yesterday that it expects to hit the high end of its second-quarter revenue guidance, and reaffirmed estimates for the full year. On the 1st Q the revenues were up 9% and the loss was cut in more than half ($0.16/shr vs. $0.35/shr in 2004) On the June Q last year the loss was $0.33/shr and revenues 18.9M CALP reportedly has around $1.56 in cash/shr and its Debt/Equt is around 0.005 Bernard